Table 3.
Statistically unique protein families in Cipangopaludina cahayensis and Pomacea canaliculata
| KO term | No. of DEGs* | No. of genes** | p-value | Pathway |
|---|---|---|---|---|
| Cipangopaludina cahayensis | ||||
| ko05145 | 87 (6.21%) | 316 (2.37%) | 8.262866e-18 | toxoplasmosis |
| ko04210 | 71 (5.06%) | 251 (1.88%) | 2.041735e-15 | apoptosis |
| ko05222 | 64 (4.56%) | 264 (1.98%) | 8.751653e-11 | small cell lung cancer |
| ko05144 | 23 (1.64%) | 55 (0.41%) | 1.741389e-09 | malaria |
| ko04621 | 47 (3.35%) | 190 (1.42%) | 1.417618e-08 | NOD-like receptor signaling pathway |
| ko05014 | 29 (2.07%) | 102 (0.76%) | 3.722068e-07 | amyotrophic lateral sclerosis (ALS) |
| ko05200 | 97 (6.92%) | 577 (4.32%) | 1.527724e-06 | pathways in cancer |
| ko05146 | 39 (2.78%) | 170 (1.27%) | 1.852183e-06 | amoebiasis |
| ko00590 | 29 (2.07%) | 119 (0.89%) | 1.106722e-05 | arachidonic acid metabolism |
| ko05416 | 35 (2.5%) | 158 (1.18%) | 1.392634e-05 | viral myocarditis |
| ko05210 | 27 (1.93%) | 116 (0.87%) | 5.248618e-05 | colorectal cancer |
| ko05323 | 20 (1.43%) | 76 (0.57%) | 7.901248e-05 | rheumatoid arthritis |
| Pomacea canaliculata | ||||
| ko00940 | 22 (1.05%) | 23 (0.17%) | 1.61937e-17 | Phenylpropanoid biosynthesis |
| ko04977 | 71 (3.4%) | 172 (1.25%) | 7.427869e-17 | vitamin digestion and absorption |
| ko00140 | 52 (2.49%) | 120 (0.87%) | 1.004048e-13 | Steroid hormone biosynthesis |
| ko04512 | 57 (2.73%) | 158 (1.14%) | 5.811497e-11 | ECM-receptor interaction |
| ko00830 | 49 (2.35%) | 126 (0.91%) | 6.057395e-11 | Retinol metabolism |
| ko00980 | 49 (2.35%) | 129 (0.93%) | 1.610139e-10 | Metabolism of xenobiotics by cytochrome P450 |
| ko00130 | 24 (1.15%) | 41 (0.3%) | 2.008634e-10 | Ubiquinone and other terpenoid-quinone biosynthesis |
| ko00591 | 45 (2.15%) | 116 (0.84%) | 4.002728e-10 | linoleic acid metabolism |
| ko00533 | 22 (1.05%) | 38 (0.28%) | 1.543998e-09 | glycosaminoglycan biosynthesis - keratan sulfate |
| ko00740 | 21 (1.01%) | 37 (0.27%) | 5.989671e-09 | riboflavin metabolism |
| ko00360 | 26 (1.24%) | 54 (0.39%) | 1.007722e-08 | Phenylalanine metabolism |
| ko00982 | 47 (2.25%) | 142 (1.03%) | 6.201926e-08 | drug metabolism-cytochrome P450 |
| ko00627 | 41 (1.96%) | 119 (0.86%) | 1.229762e-07 | aminobenzoate degradation |
| ko04142 | 84 (4.02%) | 321 (2.32%) | 1.553304e-07 | lysosome |
| ko00590 | 45 (2.15%) | 138 (1%) | 1.921892e-07 | arachidonic acid metabolism |
| ko00983 | 47 (2.25%) | 147 (1.06%) | 2.012819e-07 | drug metabolism-other enzymes |
| ko02020 | 16 (0.77%) | 31 (0.22%) | 2.208469e-06 | two-component system |
*The number of differentially expressed genes (DEGs) that belong to a KEGG pathway.
**The total number of orthologous genes that belong to a KEGG pathway.